Sir, Vascularised epiretinal membrane associated with vasoproliferative tumour
Retinal vasoproliferative tumour (VPT) is a benign entity known to be associated with epiretinal membrane (ERM) formation. The suspicion that some VPT-related membranes have vascular elements, based on clinical fundoscopic and flourescein findings is long-standing. For the first time, we present histological evidence of a vascularised ERM associated with VPT. This raises additional key questions about the aetiology of ERM and the pathogenesis of VPT.
Case report
A 34-year-old healthy post-partum female presented after a month of experiencing floaters and reduced vision in her left eye. Her unaided visual acuity was 6/4 OD and 6/24 OS.
Dilated fundoscopy of the left eye revealed a medium-sized vasoproliferative tumour (VPT), located in the inferotemporal periphery. Adjacent to the tumour were intra-retinal exudates and telangiectatic vessels, plus an overlying exudative retinal detachment ( Figure 1a ). The VPT was also associated with a vascular looking macular ERM. Fundus fluorescein angiography demonstrated late, generalised macular foveal capillary leakage.
Initially, she was treated with transconjunctival cryotherapy under local anaesthetic as she was once again pregnant. Visual acuity continued to deteriorate as a result of the ERM. On delivery a vitrectomy, membrane peel and more comprehensive cryotherapy to the VPT was undertaken under general anaesthetic (GA). The ERM was sent for histological examination. Small capillary vessels resembling diabetic neovascular membrane were present, confirming that the ERM associated with this VPT was also vascular in nature (Figure 1b) .
Comment
Vascular ERM is predominantly a finding in proliferative diabetic retinopathy (PDR).
1,2 In our Cambridge histopathological study of 207 ERMs, the only other non-PDR vascular ERM was induced by radiotherapy for basal cell carcinoma.
3 In PDR, it appears that neovascularisation is a primary event, and glial tissue proliferation a secondary phenomenon. 4 The aetiology of vascular ERM in VPT remains to be more clearly elucidated, raising further questions about the pathogenesis of both conditions. Apart from the vascular elements, the architecture and staining characteristics of this ERM was identical to nonvascularised ERM and posterior hyaloid membrane (PHM).
5 It is more-than-likely that the interplay of tumour-derived cytokines have a pivotal role in deciding the angiogenic status of VPT associated ERMs.
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The lack of previous reports of associated vascular ERM may be because of underdiagnosis of the condition. We report a case with pigment epithelial detachment (PED) that developed a retinal pigment epithelial tear after intravitreal injection of bevacizumab. This is, to our knowledge, the first report of this finding.
Case report
A 78-year-old fit patient presented with a 3week history of decreased vision and metamorphopsia in her left eye. Best-corrected snellen visual acuity (VA) in this eye was 6/12.
Fundoscopy showed subretinal fluid at the fovea with a large PED adjacent and inferior to it (Figure 1a) . These changes were secondary to age-related macular degeneration (AMD). A fundus fluorescein angiogram (FFA) confirmed the presence of a subfoveal, minimally classic, choroidal neovascular membrane (CNVM) with a fibro vascular PED (Figure 1b) . Optical coherence tomography (OCT) scans confirmed the findings (Figure 1c ). All scans were obtained with the Stratus s OCT scanner (Humphrey-Zeiss Inc., Dublin, CA, USA).
Photodynamic therapy (PDT) is contraindicated in the presence of a PED, 2-5 and therefore the patient received an intravitreal injection of 2.5 mg of bevacizumab (Avastin) with informed consent. Three weeks later left eye VA and metamorphopsia remained unchanged, although the patient had developed a retinal pigment epithelial tear inferior to the fovea ( Figure 1d ) and underwent FFA (Figure 1e ) and OCT (Figure 1f ). Hollow arrow indicates area denuded of RPE.) (e) FFA 21 s frame showed window defect corresponding to the area denuded of RPE (solid arrow) and hypofluorescence secondary blockage of choroidal fluorescence due to multilayered RPE (hollow arrow). (f) A 3 mm single line OCT scan showing fovea still apposed onto the RPE (short hollow arrow) and edge of inwardly rolled of RPE (short solid arrow) with resulting optical shadowing (long solid arrow) and increased reflectivity of outer band extent corresponding to the area denuded of RPE (long hollow arrow). VA remained unchanged as a result of the fovea remaining apposed onto the RPE despite the inferior to the fovea macular neuroretina being elevated and perpetuating the distortion of central vision.
